DELIVERY ORDER
Active75A50126F61006
Department of Health and Human Services › Office of Assistant Secretary for Preparedness and Response › BARDA - ASPR / DAAPPO / BARDA DCMA
$1M
obligated · signed 3 months ago
CHEM 2207- EVALUATION OF LYOPHILIZED ELAPID VENOM ACETYLCHOLINESTERASE AND GLYCOPYRROLATE VERSUS CRITERION STANDARD TREATMENT ON NERVE AGENT MORTALITY (ELEVATE CST STUDY)
Performance timeline
Start
Jul 16, 2026
End
Dec 15, 2027
with all options
Loading status
Estimated start: Dec 15, 2026
BATTELLE MEMORIAL INSTITUTE
Contract 75A50126F61006
UEI
F125YU6SWK59
Parent Company
BATTELLE MEMORIAL INSTITUTE
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$1,007,299
Base + Exercised Options
$1,007,299
Total Ceiling Value
$1,007,299
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Place of Performance
Congressional District: 03
Awarding Agency
Top-tier agency
Office of Assistant Secretary for Preparedness and Response
Sub-tier agency
BARDA - ASPR / DAAPPO / BARDA DCMA
Office
Funding Agency
Top-tier agency
Office of Assistant Secretary for Preparedness and Response
Sub-tier agency
BARDA - ASPR / DAAPPO / BARDA DCMA
Office
Contract Vehicle
75A50122D00007
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.